Ionis Pharmaceuticals Correlations

IONS Stock

USD 33.16 0.25 0.76%

The current 90-days correlation between Ionis Pharmaceuticals and Incyte is 0.09 (i.e., Significant diversification). The correlation of Ionis Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Ionis Pharmaceuticals Correlation With Market

Weak diversification

The correlation between Ionis Pharmaceuticals and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ionis Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ionis Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.

Moving together with Ionis Stock

0.71	CDIO	Cardio Diagnostics	Pair Corr
0.81	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.69	MRK	Merck Company	Pair Corr

Moving against Ionis Stock

0.82	PLX	Protalix Biotherapeutics	Pair Corr
0.78	GE	GE Aerospace	Pair Corr
0.66	WM	Waste Management	Pair Corr
0.58	LUCD	Lucid Diagnostics	Pair Corr
0.54	MLSS	Milestone Scientific Earnings Call This Week	Pair Corr
0.38	WMT	Walmart Aggressive Push	Pair Corr
0.72	MMM	3M Company	Pair Corr
0.69	CSCO	Cisco Systems	Pair Corr
0.64	IBM	International Business	Pair Corr
0.62	JPM	JPMorgan Chase	Pair Corr
0.61	CVX	Chevron Corp Sell-off Trend	Pair Corr
0.52	T	ATT Inc Earnings Call Today	Pair Corr
0.51	JNJ	Johnson Johnson	Pair Corr
0.43	XOM	Exxon Mobil Corp Aggressive Push	Pair Corr
0.37	INTC	Intel	Pair Corr
0.31	DD	Dupont De Nemours	Pair Corr

Related Correlations Analysis

	ARWR	BMRN	INCY	APLS	VKTX	ICPT	TERN	AKRO	RETA
ARWR		-0.66	0.6	0.73	0.54	0.0	0.68	-0.15	0.0	ARWR
BMRN	-0.66		-0.46	-0.55	-0.31	0.0	-0.45	0.18	0.0	BMRN
INCY	0.6	-0.46		0.27	0.05	0.0	0.18	0.07	0.0	INCY
APLS	0.73	-0.55	0.27		0.89	0.0	0.94	-0.54	0.0	APLS
VKTX	0.54	-0.31	0.05	0.89		0.0	0.95	-0.67	0.0	VKTX
ICPT	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	ICPT
TERN	0.68	-0.45	0.18	0.94	0.95	0.0		-0.59	0.0	TERN
AKRO	-0.15	0.18	0.07	-0.54	-0.67	0.0	-0.59		0.0	AKRO
RETA	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		RETA
	ARWR	BMRN	INCY	APLS	VKTX	ICPT	TERN	AKRO	RETA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TERN	+ 0.95	VKTX
TERN	+ 0.94	APLS
VKTX	+ 0.89	APLS
APLS	+ 0.73	ARWR
TERN	+ 0.68	ARWR
INCY	+ 0.6	ARWR

High negative correlations

AKRO	- 0.67	VKTX
BMRN	- 0.66	ARWR
AKRO	- 0.59	TERN
APLS	- 0.55	BMRN
AKRO	- 0.54	APLS
INCY	- 0.46	BMRN

Risk-Adjusted Indicators

There is a big difference between Ionis Stock performing well and Ionis Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ionis Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ARWR	2.71	(0.41)	0.00	(0.29)	0.00	0.00	4.71	(6.35)	19.61
BMRN	1.17	0.12	0.10	1.95	1.60	(1.11)	3.04	(3.32)	8.07
INCY	1.43	(0.12)	0.00	(0.48)	0.00	0.00	2.63	(4.30)	12.72
APLS	2.14	(0.37)	0.00	(0.43)	0.00	0.00	4.11	(4.33)	20.77
VKTX	3.69	(0.56)	0.00	(0.90)	0.00	0.00	8.39	(10.98)	24.65
ICPT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
TERN	3.05	(0.92)	0.00	(1.16)	0.00	0.00	5.03	(6.98)	19.13
AKRO	4.30	1.28	0.36	0.70	2.89	(5.76)	4.92	(5.64)	104.81
RETA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Ionis Pharmaceuticals Corporate Management

Brett Monia	Sr. VP of Drug Discovery and Corporate Devel.	Profile
Patrick Esq	Chief VP	Profile
Eric Swayze	Executive Research	Profile
Hayley Soffer	Vice Communications	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC